Ascendis Pharma Valuation
| ASND Stock | USD 145.23 0.81 0.55% |
At this time, the firm appears to be overvalued. Ascendis Pharma AS shows a prevailing Real Value of $72.67 per share. The current price of the firm is $145.23. Our model approximates the value of Ascendis Pharma AS from analyzing the firm fundamentals such as profit margin of (1.81) %, and Return On Equity of -8.18 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Ascendis Pharma's valuation include:
Price Book 14.5547 | Enterprise Value 8.5 B | Enterprise Value Ebitda (20.75) | Price Sales 30.9989 | Enterprise Value Revenue 31.9814 |
Overvalued
Today
Please note that Ascendis Pharma's price fluctuation is very steady at this time. Calculation of the real value of Ascendis Pharma AS is based on 3 months time horizon. Increasing Ascendis Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Ascendis Pharma AS is useful when determining the fair value of the Ascendis stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Ascendis Pharma. Since Ascendis Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ascendis Stock. However, Ascendis Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 145.23 | Real 72.67 | Target 0.34 | Hype 145.34 | Naive 145.09 |
The real value of Ascendis Stock, also known as its intrinsic value, is the underlying worth of Ascendis Pharma AS Company, which is reflected in its stock price. It is based on Ascendis Pharma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Ascendis Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ascendis Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ascendis Pharma AS helps investors to forecast how Ascendis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ascendis Pharma more accurately as focusing exclusively on Ascendis Pharma's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Ascendis Pharma's intrinsic value based on its ongoing forecasts of Ascendis Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Ascendis Pharma's closest peers. When choosing an evaluation method for Ascendis Pharma AS, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Ascendis Pharma Investments |
|
Ascendis Valuation Trend
Knowing Ascendis Pharma's actual value is paramount for traders to make sound investment determinations. Ascendis Pharma's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Ascendis Pharma's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Ascendis Pharma's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Ascendis Market Cap
Ascendis Pharma AS is rated fourth in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 91.27 Billion. Ascendis Pharma holds roughly 8.27 Billion in market capitalization claiming about 9% of equities under Health Care industry.Ascendis Pharma Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Ascendis Pharma's current stock value. Our valuation model uses many indicators to compare Ascendis Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ascendis Pharma competition to find correlations between indicators driving Ascendis Pharma's intrinsic value. More Info.Ascendis Pharma AS is rated below average in price to earning category among related companies. It is rated third in price to book category among related companies . The current year's Price To Book Ratio is expected to grow to -41.82. Comparative valuation analysis is a catch-all model that can be used if you cannot value Ascendis Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ascendis Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ascendis Pharma's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ascendis Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ascendis Pharma and how it compares across the competition.
About Ascendis Pharma Valuation
The stock valuation mechanism determines the current worth of Ascendis Pharma AS on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Ascendis Pharma AS. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Ascendis Pharma AS based exclusively on its fundamental and basic technical indicators. By analyzing Ascendis Pharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Ascendis Pharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ascendis Pharma. We calculate exposure to Ascendis Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ascendis Pharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 222.3 M | 233.4 M | |
| Pretax Profit Margin | (1.78) | (1.87) | |
| Operating Profit Margin | (1.71) | (1.79) | |
| Net Loss | (1.81) | (1.90) | |
| Gross Profit Margin | 0.83 | 0.57 |
8 Steps to conduct Ascendis Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ascendis Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ascendis Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ascendis Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ascendis Pharma's revenue streams: Identify Ascendis Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ascendis Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ascendis Pharma's growth potential: Evaluate Ascendis Pharma's management, business model, and growth potential.
- Determine Ascendis Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ascendis Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Ascendis Pharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Ascendis Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 56.3 M |
Ascendis Pharma Current Valuation Indicators
Valuation refers to the process of determining the present value of Ascendis Pharma AS and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Ascendis we look at many different elements of the entity such as Ascendis's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Ascendis Pharma's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Ascendis Pharma's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Ascendis Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Ascendis Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Ascendis Pharma's worth.When determining whether Ascendis Pharma AS is a strong investment it is important to analyze Ascendis Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascendis Pharma's future performance. For an informed investment choice regarding Ascendis Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ascendis Pharma AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is Ascendis Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ascendis Pharma. If investors know Ascendis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ascendis Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.19) | Revenue Per Share 4.739 | Quarterly Revenue Growth 5.014 | Return On Assets (0.30) | Return On Equity (8.18) |
The market value of Ascendis Pharma AS is measured differently than its book value, which is the value of Ascendis that is recorded on the company's balance sheet. Investors also form their own opinion of Ascendis Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ascendis Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ascendis Pharma's market value can be influenced by many factors that don't directly affect Ascendis Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ascendis Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascendis Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascendis Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.